<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_AFCM-Egypt skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:AFCM-Egypt</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>A F C M</TITLE></P><DIV class="container" style="width:95%"><DIV class="navbar-header" style="width:100%"><BUTTON type="button" id="navbar-toggle" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON><DIV class="collapse navbar-collapse" id="navbar"><DIV class="row text-center" style="margin:auto;float:none;width:fit-content"><UL id="menu" style="float: none;
    margin-right: auto;
    margin-left: auto;
    margin-top: 0px;
    display: list-item;"><LI class="HOME"><A href="https://2017.igem.org/Team:AFCM-Egypt">HOME</A></LI><LI class="Meet"><A>TEAM </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Meet_the_team">Meet The Team</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Collaborations">Collaborations</A></LI></UL><LI class="PROJECT"><A>PROJECT </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Description">Project Description</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Experiments">Experiment</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Demonstrate">Proof of concept</A></LI><LI class="PARTS"><A>PARTS </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Basic_Part">Parts</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Basic_Part">Basic Parts</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Composite_Part">Composite Parts</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/Improve">Improve</A></LI><LI class="Design"><A href="https://2017.igem.org/Team:AFCM-Egypt/Design">Design</A></LI><LI class="MODELING"><A href="https://2017.igem.org/Team:AFCM-Egypt/Model">MODELING</A></LI><LI class="SOFTWARE"><A href="https://2017.igem.org/Team:AFCM-Egypt/Software">Software</A></LI><LI class="SAFETY"><A href="https://2017.igem.org/Team:AFCM-Egypt/Safety">SAFETY</A></LI><LI class="HUMAN"><A>HUMAN PRACTICE </A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/HP/Silver">Silver</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/HP/Gold">Gold</A></LI><LI><A href="https://2017.igem.org/Team:AFCM-Egypt/HP/Integrated">Integrated</A></LI><LI class="ATTRIBUTIONS"><A href="https://2017.igem.org/Team:AFCM-Egypt/Attributions">ATTRIBUTIONS</A></LI><LI class="CRITERIA"><A href="https://2017.igem.org/Team:AFCM-Egypt/Medal_criteria">MEDAL CRITERIA</A></LI></DIV></DIV></DIV></DIV><TITLE>A F C M</TITLE><SECTION class="price-table"><DIV class="container section-wrapper"><DIV class="row" style="margin-bottom: 50px;"><DIV class="col-md-6 text-center" style="float: none;height: auto ; width: 90%; margin: auto; background-color: rgba(0, 0, 0, 0.4);"><H3 dir="ltr" style="text-align: left;"><SPAN style="font-size: 20pt; color: #ffffff;">Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma</SPAN></H3><H3 class="text-center" style="text-align: center;"><SPAN style="font-size: 14pt; color: #ffffff;">Abstract</SPAN></H3><P style="text-align: left;"><SPAN style="font-size: 14pt; color: #ffffff;"> </SPAN></P><SPAN style="font-size: 14pt; color: #ffffff;">Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide &amp; ranked first among cancers in males and next to breast cancer among females in</SPAN><SPAN style="font-size: 14pt; color: #ffffff;"> Egypt based upon results of National Cancer Registry Program of Egypt. &quot;Grabbing the problem from the roots&quot; is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain  circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies  miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.  This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is   accomplished by utilizing a  synthetic circuit to give rise to a springboard in our battle against cancer.</SPAN></DIV></DIV></DIV></SECTION><DIV class="twitter-feed purple" style="margin-bottom:50vh;background-color: rgba(0, 0, 0, 0.4);"><DIV class="container section-wrapper"><DIV class="col-md-6 text-center"><H2 class="text-center" style="margin-bottom:30px">
                    AFCM-Egypt</H2><H3 class="text-center">
                        A Culture of Discipline and Innovation</H3><A href="http://www.afcm.ac.eg/" class="btn btn-primary btn-outline with-arrow" target="_blank"> click here </A></DIV></DIV></DIV><SECTION class="section-wrapper add container" style="background-color:#808387;width:100%"><DIV class="slider-wrapper theme-mi-slider"><H3 class="text-center">OUR SPONSORS</H3><DIV class="afcmslider-holder"><BUTTON class="afcmcontrols" id="afcmcontrols-left">❮</BUTTON><BUTTON class="afcmcontrols" id="afcmcontrols-right">❯</BUTTON></DIV></DIV></SECTION></DIV></DIV></DIV></DIV></DIV></BODY></HTML>